HK1182716A1 - 氧化磷脂 - Google Patents

氧化磷脂

Info

Publication number
HK1182716A1
HK1182716A1 HK13110017.3A HK13110017A HK1182716A1 HK 1182716 A1 HK1182716 A1 HK 1182716A1 HK 13110017 A HK13110017 A HK 13110017A HK 1182716 A1 HK1182716 A1 HK 1182716A1
Authority
HK
Hong Kong
Prior art keywords
oxidized phospholipids
phospholipids
oxidized
Prior art date
Application number
HK13110017.3A
Other languages
English (en)
Inventor
Gideon Halperin
Eti Kovalevski-Ishai
Original Assignee
Vascular Biogenics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vascular Biogenics Ltd filed Critical Vascular Biogenics Ltd
Publication of HK1182716A1 publication Critical patent/HK1182716A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK13110017.3A 2004-07-09 2007-05-31 氧化磷脂 HK1182716A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58621904P 2004-07-09 2004-07-09

Publications (1)

Publication Number Publication Date
HK1182716A1 true HK1182716A1 (zh) 2013-12-06

Family

ID=35784252

Family Applications (2)

Application Number Title Priority Date Filing Date
HK07105789.7A HK1100526A1 (en) 2004-07-09 2007-05-31 Improved process for the preparation of oxidized phospholipids
HK13110017.3A HK1182716A1 (zh) 2004-07-09 2007-05-31 氧化磷脂

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK07105789.7A HK1100526A1 (en) 2004-07-09 2007-05-31 Improved process for the preparation of oxidized phospholipids

Country Status (14)

Country Link
EP (3) EP1773352B1 (zh)
JP (3) JP4767948B2 (zh)
KR (1) KR101201935B1 (zh)
CN (3) CN103880876A (zh)
CA (1) CA2573396C (zh)
ES (1) ES2439450T3 (zh)
HK (2) HK1100526A1 (zh)
IL (2) IL180628A (zh)
MX (1) MX2007000361A (zh)
NZ (2) NZ553147A (zh)
PL (1) PL1773352T3 (zh)
RU (1) RU2399626C2 (zh)
WO (1) WO2006006161A2 (zh)
ZA (1) ZA200701178B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6838452B2 (en) 2000-11-24 2005-01-04 Vascular Biogenics Ltd. Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
US7807847B2 (en) 2004-07-09 2010-10-05 Vascular Biogenics Ltd. Process for the preparation of oxidized phospholipids
US8569529B2 (en) 2007-01-09 2013-10-29 Vascular Biogenics Ltd. High-purity phospholipids
US9006217B2 (en) 2007-01-09 2015-04-14 Vascular Biogenics Ltd. High-purity phospholipids
US8999960B2 (en) 2008-10-08 2015-04-07 Vascular Biogenics Ltd. Oxidized thiophospholipid compounds and uses thereof
EP2348866B1 (en) * 2008-11-06 2015-01-07 Vascular Biogenics Ltd. Oxidized lipid compounds and uses thereof
WO2011083469A1 (en) * 2010-01-05 2011-07-14 Vascular Biogenics Ltd. Treatment with vb-201
WO2012119781A2 (en) * 2011-03-10 2012-09-13 University Of Geneva Novel lipids, phospholipids, phospholipid and lipid compositions and their use
AU2012301602B2 (en) 2011-09-01 2015-09-03 Vascular Biogenics Ltd. Formulations and dosage forms of oxidized phospholipids
CA2968790A1 (en) 2014-11-26 2016-06-02 Vascular Biogenics Ltd. Oxidized lipids and treatment or prevention of fibrosis
US9771385B2 (en) 2014-11-26 2017-09-26 Vascular Biogenics Ltd. Oxidized lipids
CN105622665B (zh) * 2016-03-16 2017-11-24 北京美亚斯磷脂技术有限公司 一种改性大豆磷脂的制备方法
CN112592265B (zh) * 2020-12-21 2023-09-01 安达兰泽科技有限公司 3,3-二甲基-2-氧代丁酸及其钠盐的制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3022A (en) * 1843-03-30 Machine for bending stibrups for paddle-wheels of steam and other
CH642665A5 (en) 1979-02-08 1984-04-30 Rudolf Berchtold Process for the preparation of 1-(omega-carboxyalkyl)-2-alkyl- glycero-3-phosphatides
US4329302A (en) 1980-06-27 1982-05-11 Board Of Regents, The University Of Texas System Synthetic phosphoglycerides possessing platelet activating properties
US4614796A (en) 1983-03-25 1986-09-30 Nippon Shinyaku Co., Ltd. Liposome and method of manufacture therefor
US4827011A (en) 1984-12-10 1989-05-02 American Cyanamid Company Antihypertensive phosphate derivatives
DE3663522D1 (en) 1985-11-29 1989-06-29 Takeda Chemical Industries Ltd Phospholipid derivatives, their production and use
JPS6354386A (ja) * 1986-08-26 1988-03-08 Takeda Chem Ind Ltd リン脂質およびその用途
JP2534894B2 (ja) * 1988-06-24 1996-09-18 日本ケミファ株式会社 新規なグリセリン誘導体およびその誘導体を含有する血圧降下剤
JPH03258740A (ja) * 1990-03-06 1991-11-19 Kao Corp 液体油、その製造法及びこれを含有する化粧料
JP2869572B2 (ja) * 1990-05-14 1999-03-10 和光純薬工業株式会社 ホスファチジルコリン誘導体の製造方法
US5561052A (en) 1992-06-18 1996-10-01 Koike; Katsumasa Process for detecting oxidized lipids and process for forming oxidized lipids
FR2714382B1 (fr) 1993-12-27 1996-02-02 Roussel Uclaf Phospholipides vecteur de molécule active, leur préparation et leur utilisation dans des compositions cosmétiques ou dermatologiques.
AU1751795A (en) 1994-03-04 1995-09-18 University Of British Columbia, The Liposome compositions and methods for the treatment of atherosclerosis
JPH08208548A (ja) * 1995-02-01 1996-08-13 Kao Corp グリセリン誘導体の製造法
US5660855A (en) 1995-02-10 1997-08-26 California Institute Of Technology Lipid constructs for targeting to vascular smooth muscle tissue
US6261597B1 (en) 1995-08-31 2001-07-17 Seymour J. Kurtz Method for treating periodontal disease
US6096291A (en) 1996-12-27 2000-08-01 Biovector Therapeutics, S.A. Mucosal administration of substances to mammals
US6376450B1 (en) 1998-10-23 2002-04-23 Chanchal Kumar Ghosh Cleaning compositions containing multiply-substituted protease variants
IL155619A0 (en) * 2000-11-07 2003-11-23 I R B Istituto Di Ricerche Bio Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
US6838452B2 (en) 2000-11-24 2005-01-04 Vascular Biogenics Ltd. Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
KR100865142B1 (ko) * 2000-11-24 2008-10-24 바스큘라 바이오제닉스 리미티드 죽상 경화증의 예방 및 치료를 위해 정의된 산화 인지질을사용하는 방법 및 이를 함유하는 조성물
CN1247599C (zh) * 2001-08-08 2006-03-29 中国科学院福建物质结构研究所 生物膜磷脂酸的过渡金属盐及其合成方法
DE10155095A1 (de) * 2001-11-09 2003-05-22 Cognis Deutschland Gmbh Alkyl(en)ylglycerinethercarbonsäuren

Also Published As

Publication number Publication date
JP5655117B2 (ja) 2015-01-14
EP2604614A3 (en) 2013-07-17
CN101891760A (zh) 2010-11-24
CN101039680B (zh) 2011-08-03
ES2439450T3 (es) 2014-01-23
CN103880876A (zh) 2014-06-25
EP2604614B1 (en) 2016-03-09
EP1773352A2 (en) 2007-04-18
PL1773352T3 (pl) 2014-04-30
RU2399626C2 (ru) 2010-09-20
CN101891760B (zh) 2014-05-07
JP4767948B2 (ja) 2011-09-07
WO2006006161A2 (en) 2006-01-19
IL180628A (en) 2011-11-30
EP1773352A4 (en) 2009-12-30
EP2604614A2 (en) 2013-06-19
WO2006006161A3 (en) 2006-10-12
MX2007000361A (es) 2008-03-05
IL211796A0 (en) 2011-05-31
CN101039680A (zh) 2007-09-19
JP5421858B2 (ja) 2014-02-19
NZ553147A (en) 2010-07-30
CA2573396C (en) 2015-07-07
JP2010209107A (ja) 2010-09-24
RU2007105097A (ru) 2008-08-20
ZA200701178B (en) 2008-09-25
EP1773352B1 (en) 2013-10-09
KR20070054632A (ko) 2007-05-29
JP2013231060A (ja) 2013-11-14
HK1100526A1 (en) 2007-09-21
NZ586503A (en) 2011-06-30
IL180628A0 (en) 2007-06-03
CA2573396A1 (en) 2006-01-19
IL211796A (en) 2015-04-30
KR101201935B1 (ko) 2012-11-16
EP2574612A1 (en) 2013-04-03
JP2008505885A (ja) 2008-02-28

Similar Documents

Publication Publication Date Title
HK1182716A1 (zh) 氧化磷脂
TWI340728B (en) Elevator
ZA200700942B (en) Compressor-distractor
AP2006003810A0 (en) 4-Phenylamino-quinazolin-6-yl-amides
EP1790612A4 (en) NANOCAPSULE TYPE STRUCTURE
HK1087391A1 (en) Elevator
DE602004014986D1 (en) Terminal-box
ZA200703510B (en) DVTdetection
GB2417615B (en) Stator structures
EP1831161A4 (en) 2-METHYLENE-19-NOR (20R) -1-alpha-hydroxy-BISHOMOPREGNACALCIFEROL
EP1767485A4 (en) ELEVATOR
EP1717185A4 (en) ELEVATOR
GB0425932D0 (en) Structured phospholipids
EP1760030A4 (en) LIFT
GB0413160D0 (en) Autopark
EP1714934A4 (en) LIFT
EP1717184A4 (en) ELEVATOR
GB0500336D0 (en) Elevator f
GB0402953D0 (en) Elevator III
AU2909P (en) DT23 Dianella tasmanica
GB0402454D0 (en) Elevator II
GB0400279D0 (en) Elevator
GB0405970D0 (en) Concept seven
GB0406253D0 (en) Concept 12 - twelve
AU155980S (en) Section

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230710